NO20084897L - Ny forbindelse med affinitet til amuloid - Google Patents

Ny forbindelse med affinitet til amuloid

Info

Publication number
NO20084897L
NO20084897L NO20084897A NO20084897A NO20084897L NO 20084897 L NO20084897 L NO 20084897L NO 20084897 A NO20084897 A NO 20084897A NO 20084897 A NO20084897 A NO 20084897A NO 20084897 L NO20084897 L NO 20084897L
Authority
NO
Norway
Prior art keywords
compound
affinity
amuloid
integer
new compound
Prior art date
Application number
NO20084897A
Other languages
English (en)
Inventor
Daisaku Nakamura
Shigeyuki Tanifuji
Shinya Takasaki
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of NO20084897L publication Critical patent/NO20084897L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Det beskrives en forbindelse som har affinitet med amyloid, viser tilstrekkelig hurtig klaring fra normalvev og har redusert toksisitet som for eksempel mutagenisitet. Det beskrives videre et lavtoksisk, diagnostisk middel mot Alzheimers sykdom inneholdende denne forbindelse. Forbindelsen er representert ved formel (1) eller et salt derav, der A1, A2, A3 og A4 uavhengig er et karbon- eller nitrogenatom, og der R er en radioaktiv halogensubstituent; m er et heltall 0 til 4; og n er et heltall 0 eller 1, forutsatt at minst én av A1, A2, A3 og A4 er et karbonatom, og R3 binder til et karbon-atom representert ved A1, A2, A3 eller A4.
NO20084897A 2006-04-28 2008-11-20 Ny forbindelse med affinitet til amuloid NO20084897L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006124811 2006-04-28
PCT/JP2007/059048 WO2007125988A1 (ja) 2006-04-28 2007-04-26 新規アミロイド親和性化合物

Publications (1)

Publication Number Publication Date
NO20084897L true NO20084897L (no) 2009-01-15

Family

ID=38655513

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084897A NO20084897L (no) 2006-04-28 2008-11-20 Ny forbindelse med affinitet til amuloid

Country Status (16)

Country Link
US (2) US8022207B2 (no)
EP (1) EP2022792B1 (no)
JP (1) JP5048655B2 (no)
KR (1) KR20080112343A (no)
CN (1) CN101472923A (no)
AT (1) ATE493410T1 (no)
AU (1) AU2007244313B2 (no)
CA (1) CA2657312A1 (no)
DE (1) DE602007011601D1 (no)
ES (1) ES2355079T3 (no)
IL (1) IL194889A0 (no)
NO (1) NO20084897L (no)
NZ (1) NZ572741A (no)
RU (1) RU2008147002A (no)
TW (1) TW200803903A (no)
WO (1) WO2007125988A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008150377A (ru) 2006-05-19 2010-06-27 Нихон Меди-Физикс Ко., Лтд. (Jp) Новое соединение, обладающее сродством к амилоиду
EP2098523A4 (en) * 2006-11-17 2011-09-21 Nihon Mediphysics Co Ltd NEW, AMYLOID-AFFINE COMPOUNDS
AU2007326707A1 (en) 2006-11-30 2008-06-05 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
EP2213672A4 (en) * 2007-10-24 2012-05-02 Nihon Mediphysics Co Ltd NEW CONNECTION WITH AFFINITY TO AMYLOID
EP2213671A4 (en) * 2007-10-26 2012-02-22 Nihon Mediphysics Co Ltd NEW CONNECTION WITH AFFINITY TO AMYLOID
JPWO2009057575A1 (ja) * 2007-10-30 2011-03-10 日本メジフィジックス株式会社 新規アミロイド親和性化合物の使用及び製造方法
EP2218464A1 (en) * 2009-02-11 2010-08-18 Technische Universität München Compounds for non-invasive measurement of aggregates of amyloid peptides
US9926316B2 (en) * 2016-03-03 2018-03-27 The Cleveland Clinic Foundation Antitumor derivatives for differentiation therapy
CN108822105A (zh) * 2018-08-14 2018-11-16 河南师范大学 一种由乙苯类化合物合成2-芳基咪唑并[1,2-a]吡啶类化合物的方法
US12551576B2 (en) 2020-01-31 2026-02-17 The General Hospital Corporation Chemiluminescent probes

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871745A (en) * 1986-09-22 1989-10-03 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents
US4727145A (en) * 1986-09-22 1988-02-23 Ortho Pharmaceutical Corporation 2- Or 3- aryl substituted imidazo [1,2-a]pyridines
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
US4833149A (en) * 1986-09-22 1989-05-23 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines
KR19990064310A (ko) * 1995-10-17 1999-07-26 윌리암스 로저 에이 시클로옥시게나제-2의 검출방법
US6812327B1 (en) * 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
JP3980833B2 (ja) * 1998-08-20 2007-09-26 リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア βアミロイド斑及び神経原線維変化の標識方法
US20010051632A1 (en) * 2000-03-31 2001-12-13 Wenying Chai Phenyl-substituted indolizines and tetrahydroindolizines
US6514969B2 (en) * 2000-08-16 2003-02-04 Boehringer Ingelheim Pharma Kg β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions
DE10040016A1 (de) 2000-08-16 2002-02-28 Boehringer Ingelheim Pharma Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DK1334091T3 (da) 2000-08-24 2012-10-15 Univ Pittsburgh Thioflavinderivater og deres anvendelse til diagnose og terapi af Alzheimer's sygdom
CZ20032597A3 (cs) * 2001-02-26 2004-12-15 Bristol-Myers Squibb Pharma Company Analogy kyseliny askorbové pro metaloradiofarmaceutika
US6596731B2 (en) * 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
ES2274973T3 (es) * 2001-04-23 2007-06-01 The Trustees Of The University Of Pennsylvania Inhibidores de la agregacion de placas amiloides y agentes de obtencion de imagenes diagnosticas.
CN101003526B (zh) * 2001-08-27 2012-02-22 宾夕法尼亚州大学理事会 茋衍生物及其用于结合和成像淀粉样蛋白斑的用途
GB0205281D0 (en) * 2002-03-06 2002-04-17 Novartis Ag Organic compounds
EP1356827A1 (en) * 2002-04-24 2003-10-29 Mallinckrodt Inc. Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
AU2003242233A1 (en) 2002-06-12 2003-12-31 Bf Research Institute, Inc. Probe compound for image diagnosis of disease with amyloid accumulation, compound for staining age spots/diffuse age spots, and remedy for disease with amyloid accumulation
US20050260126A1 (en) * 2002-08-30 2005-11-24 Yukitsuka Kudo Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
GB0229695D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids
PL380764A1 (pl) * 2003-12-31 2007-03-19 Schering-Plough Ltd. Kontrolowanie pasożytów u zwierząt za pomocą stosowania imidazo [1,2-b] pirydazynowych pochodnych
RU2008150377A (ru) 2006-05-19 2010-06-27 Нихон Меди-Физикс Ко., Лтд. (Jp) Новое соединение, обладающее сродством к амилоиду
AU2007261985B2 (en) 2006-06-21 2012-04-19 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
EP2098523A4 (en) 2006-11-17 2011-09-21 Nihon Mediphysics Co Ltd NEW, AMYLOID-AFFINE COMPOUNDS
AU2007326707A1 (en) * 2006-11-30 2008-06-05 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
EP2213672A4 (en) * 2007-10-24 2012-05-02 Nihon Mediphysics Co Ltd NEW CONNECTION WITH AFFINITY TO AMYLOID
EP2213671A4 (en) * 2007-10-26 2012-02-22 Nihon Mediphysics Co Ltd NEW CONNECTION WITH AFFINITY TO AMYLOID
KR20100101577A (ko) * 2007-10-30 2010-09-17 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물의 사용 및 제조 방법

Also Published As

Publication number Publication date
TW200803903A (en) 2008-01-16
EP2022792A8 (en) 2009-04-29
ATE493410T1 (de) 2011-01-15
WO2007125988A1 (ja) 2007-11-08
JPWO2007125988A1 (ja) 2009-09-10
EP2022792B1 (en) 2010-12-29
US20110201808A1 (en) 2011-08-18
IL194889A0 (en) 2011-08-01
NZ572741A (en) 2010-07-30
US20100249407A1 (en) 2010-09-30
AU2007244313B2 (en) 2011-09-08
DE602007011601D1 (de) 2011-02-10
US8022207B2 (en) 2011-09-20
CA2657312A1 (en) 2007-11-08
KR20080112343A (ko) 2008-12-24
RU2008147002A (ru) 2010-06-10
ES2355079T3 (es) 2011-03-22
JP5048655B2 (ja) 2012-10-17
EP2022792A1 (en) 2009-02-11
EP2022792A4 (en) 2009-11-11
AU2007244313A1 (en) 2007-11-08
CN101472923A (zh) 2009-07-01

Similar Documents

Publication Publication Date Title
NO20085265L (no) Nye forbindelser som har affinitet for amyloid
NO20090233L (no) Ny sammensetning som har affinitet for amyloid
ATE493410T1 (de) Neue verbindung mit affinität zu amyloid
WO2009054497A1 (ja) 新規アミロイド親和性化合物
NO20092248L (no) Ny forbindelse med affinitet for amyloid
NO20076524L (no) Pyrazolforbindelse samt terapeutisk middel for diabetes som omfatter det samme
NO20074718L (no) BCRP/ABCG2 inhibitor
NO20065578L (no) Substituerte metylaryl eller heteroarylamidforbindelser
BR112012033770A2 (pt) novo derivado de nicotinamida ou sal do mesmo
NO20074443L (no) Fremgangsmate for svak fordelingskromatografi
NO20065573L (no) Orto-substituerte aryl eller heteroarylamidforbindelser
TW200716619A (en) Heterocyclic compound
BRPI0510305A (pt) composto ou um sal do mesmo, pródroga ou um sal da mesma, agente farmacêutico, método de produção do composto ou um sal do mesmo, inibidor de metaloproteinase de matriz ou um sal do mesmo ou uma pródroga do mesmo, método de inibir uma metaloproteinase de matriz, e, uso de um composto ou de um sal do mesmo ou de uma pródroga do mesmo
WO2009054496A1 (ja) 新規アミロイド親和性化合物
CL2008002703A1 (es) Compuestos derivados de 1,4-dihidro-2h-piridazin-3-ona; composicion herbicida que comprende a dichos compuestos; metodo de control de malezas; uso de dichos compuestos para el control de malezas; y compuestos intermediarios.
WO2010053583A3 (en) Small molecule cd4 mimetics and uses thereof
NO20082805L (no) Bicykliske cinnamidforbindelser
BR112012032813A2 (pt) composto, composição farmacêutica, e, método para prevenir, tratar ou melhorar uma doença ou condição.
CY1113320T1 (el) Σπειρο-κυκλικα νιτριλια ως αναστολεις πρωτεασης
NO20081621L (no) Tetrahydrokinoliner, syntese og intermediater
SG161217A1 (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
MXPA05013652A (es) Modulador del receptor canabinoide.
BRPI0606845A2 (pt) derivados de (1,5-difenil-1h-pirazol-3-il)oxadiazol, o respectivo preparo e a respectiva aplicação em terapêutica
EA200970555A1 (ru) Трициклическое соединение и его медицинское применение
DK2046754T3 (da) Fremgangsmåde til fremstilling af alkylanilider ud fra halogenbenzenderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application